Serenex

20 articles about Serenex

• NC Judge Awards $57 Million to Durham Drug Company, Serenex

  9/5/2008

• Coserics Announces Company Formation Including Spin-Out of Phase 2 Clinical Asset From Serenex

  4/17/2008

• Serenex Announces Collaboration With National Cancer Institute to Initiate Clinical Trial With Serenex's Proprietary Small Molecule HSP90 Inhibitor, SNX-5422

  2/27/2008

• Serenex Announces Collaboration With National Cancer Institute to Evaluate Proprietary Small Molecule Hsp90 Inhibitors as a Potential Treatment for Lung Cancer

  1/24/2008

• Multiple Myeloma Research Foundation (MMRF) Grants $3.5 Million in Biotech Investment Awards

  1/23/2008

• Serenex and CHDI, Inc. Form Agreement to Evaluate Proprietary Small Molecule Hsp90 Inhibitors as a Potential Treatment for Huntington's Disease

  1/17/2008

• Serenex Announces Initiation of Second Phase 1 Trial for Oral Hsp90 Inhibitor, SNX-5422

  12/4/2007

• Serenex to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference

  10/23/2007

• Serenex to Present at Biotechnology Industry Organization (BIO) Investor Forum 2007

  10/9/2007

• Serenex Announces Initiation of Phase 1 Trial for Oral Hsp90 Inhibitor, SNX-5422

  5/31/2007

• Senior Development Executive Joins Serenex

  5/15/2007

• Serenex Announces Participation at the 2007 Biotechnology Industry Organization (BIO) Business Forum

  5/3/2007

• Serenex Invited to Present at the BioCentury and Thomson Financial -- "Future Leaders in The Biotech Industry"

  3/22/2007

• Serenex Announces Issuance of European Patent for Oral Mucositis Product SNX-1012

  3/20/2007

• Serenex To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/7/2007

• Serenex Announces Participation At Biotechnology Industry Organization (BIO) InvestorForum

  10/18/2006

• Serenex Announces The Start Of A Phase 2 Clinical Trial Of SNX-1012 For The Treatment Of Chemotherapy-Induced Oral Mucositis

  7/12/2006

• Serenex To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/9/2006

• Senior Research And Development Executives Join Serenex

  11/16/2005

• 14th Annual Report: Top 100 Biotechnology Companies

  7/12/2005